Foreign Investment Reshaping Cyprus’ Private Healthcare Landscape

by THEFUTURE.TEAM

September 19, 2025

Introduction

At the 8th Cyprus Healthcare Conference, organized by Ygia Polyclinic Private Hospital, industry experts scrutinized the transformative role of foreign capital in the nation’s private healthcare sector. This evolving trend, driven by multinational acquisitions and technological advancements, is redefining Cyprus as a regional medical hub.

Foreign Capital and Industry Transformation

Analysts at the conference delved into how acquisitions by global healthcare conglomerates are introducing advanced technology, improved services, and innovative practices to the island. As major hospitals change ownership and new facilities emerge, foreign investment is not only altering the healthcare landscape but also provoking critical debates over market competition, quality of care, and the future role of government oversight.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Market Consolidation and Strategic Dynamics

Industry leaders, including Andreas Georgallis of ECM Cyprus and deputy chairman of Ygia Polyclinic, emphasized that factors such as an aging demographic, political stability, and a favorable tax regime are attracting investors. The implementation of the national health scheme, Gesy, further solidified economic predictability, thereby encouraging further investment. Iakovos Galanos, managing director and COO at KPMG, noted that market consolidation, a trend that began in the United States and advanced through Europe and Greece, now has significant implications for Cyprus, potentially diminishing competition within the sector.

Regulatory Oversight and Quality of Care

Concerns about reduced competition and the integrity of care standards were raised, with analysts suggesting that the state health services organization must ensure a level playing field. While studies on quality of care offer mixed findings, the integration of new technologies and proven international practices is widely recognized as a catalyst for enhancing service delivery and patient outcomes.

Patient-Centric Innovations

Polis Georghades, CEO of El Greco Medical Centre, highlighted the patient-centric impact of these developments. The introduction of Gesy has empowered Cypriot patients by granting them greater choice in healthcare providers—a right long established in Europe. Internationally adopted practices, brought in by foreign investors, have further enriched the sector by embedding quality indicators into reimbursement models and accreditation processes since 2015.

Conclusion

Foreign investment is catalyzing profound changes in Cyprus’ private healthcare sector. As the country positions itself as a regional leader in medical services, the interplay of market consolidation, regulatory evolution, and quality improvements will continue to shape its future. Industry stakeholders remain vigilant, recognizing that while foreign capital brings substantial benefits, a balanced approach is necessary to sustain competitive, high-quality healthcare services.

The Future Forbes Realty Global Properties

Bank of Cyprus Upgrade Signals Fresh Optimism For Greek And Cypriot Banks

by THEFUTURE.TEAM

June 26, 2026

Regional Banks Enter A More Favorable Cycle

Bank of Cyprus and Eurobank are well positioned to benefit from a renewed re-rating of Greek and Cypriot bank stocks, according to Cyprus-based investment firm Roemer Capital, which upgraded Bank of Cyprus to a buy rating and reaffirmed its positive view on Eurobank.

The firm cited easing geopolitical tensions, resilient economic growth in Greece and Cyprus, lower funding costs and Greece’s expected transition to developed-market status as the main factors supporting the sector.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Roemer Capital also lowered its cost of equity assumptions, updated its forecasts following first-quarter 2026 results and extended its valuation horizon to the end of 2027, raising target prices across its banking coverage.

Bank Of Cyprus Gets The Largest Upgrade

Bank of Cyprus received the biggest revision, with Roemer Capital upgrading the stock from hold to buy and setting a target price of €11.10, implying potential total upside of 27%.

The firm highlighted the bank’s strong capital generation, profitability and projected 100% dividend payout, describing it as the strongest capital-return story among the banks under coverage. Roemer Capital maintained its buy rating on Eurobank, assigning a target price of €4.90 and forecasting potential upside of 28%. The report said the bank is well placed to benefit from loan growth, improving operating performance and merger-and-acquisition synergies.

National Bank of Greece and Piraeus Bank also retained buy ratings, with expected returns ranging from 25% to 36%. Optima Bank was upgraded to buy, while Alpha Bank remained at hold on valuation grounds.

Why Growth Still Sets The Region Apart

According to Roemer Capital, Greek and Cypriot banks continue to benefit from stronger economic fundamentals than many western European peers. The report pointed to faster economic growth, healthier balance sheets, low levels of non-performing exposures, capital ratios approaching 20% and strong customer deposit bases.

Analysts expect performing loans across the sector to grow at a compound annual rate of 6% to 8% through 2028, supported by private investment, digitalisation, green manufacturing, supply-chain expansion and a gradual recovery in household lending.

The report also said the conclusion of lending under the EU Recovery and Resilience Facility is unlikely to materially affect credit growth, as banks have already shifted back towards traditional commercial lending. Roemer Capital expects Euribor to remain between 2.2% and 2.5%, a level it believes should support both lending activity and net interest margins.

Geopolitics, Valuation And Market Structure Support The Case

The report said improving geopolitical conditions have strengthened the investment outlook, noting that Brent crude prices have largely returned to pre-war levels while Greek government bond yields have stabilised at around 3.5%. Although geopolitical risks remain, Roemer Capital believes the likelihood of a major inflationary shock or significant pressure on bank profitability has eased.

Another important catalyst identified by the firm is Greece’s expected promotion to developed-market status by FTSE Russell, STOXX and MSCI over the coming months.

According to the report, the reclassification should improve liquidity and attract a broader base of international investors. Roemer Capital also said Euronext’s acquisition of the Athens Exchange is expected to strengthen market infrastructure and increase international visibility, particularly for Bank of Cyprus and Optima Bank.

The firm noted that Bank of Cyprus has already benefited from its Athens listing, with average daily trading value increasing from less than €400,000 before its September 2024 move to nearly €6 million afterwards.

Economic Momentum Remains A Core Tailwind

Roemer Capital said both Greece and Cyprus have moved beyond post-crisis recovery and are now supported by private-sector-led growth. For Cyprus, the report highlighted recent tax reform and efforts to simplify the legal and regulatory framework, while also noting that limited foreign banking competition continues to support domestic lenders.

Overall, Roemer Capital expects Greek and Cypriot banks to remain well-positioned for profitable loan growth over the coming years.

Breaking news